Work

Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer’s Disease: A Phase II Double-Blind Placebo-Controlled Trial

Year: 2021

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Alzheimer s Disease

DOI: 10.3233/jad-210011

Authors: Jonas Hannestad, Tiffanie Duclos, Whitney Chao, Katie Koborsi, Vicki Klutzaritz, Brian Beck, Ashok K. Patel, James Scott, Stephen G. Thein, Jeffrey L. Cummings, Gary Kay, Steven Braithwaite, Karoly Nikolich

Institutions: Alkahest, Inc. (United States), Riverside Clinical Research, University of Nevada, Las Vegas, Cognitive Research (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute on Aging, National Institute of General Medical Sciences

Awards: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission, Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative

OpenAlex ID: W3158757170

FWCI: 2.667

Cites: 46

Cited by: 24

Related to: 10